32 genes linked to long COVID — while vaccination cuts risk, but doesn't eliminate it
New research is painting a clearer picture of long COVID—from the genes that may predispose people to it, to how vaccines affect outcomes, to the specific ways it impacts daily life and work.
🧬 Scientists identify 32 genes that may cause long COVID
Researchers used advanced genetic analysis to identify 32 candidate genes linked to long COVID, including 19 previously known and 13 newly discovered ones
The genes are involved in immune regulation, viral response, and cell cycle control—suggesting multiple biological pathways contribute to persistent symptoms
Using these genetic profiles, they identified three distinct subtypes of long COVID based on symptom patterns, which could help explain why the condition varies so much between patients
Why it matters: This genetic roadmap could lead to personalized treatments and help predict who's most at risk for developing long COVID after infection.
Key Findings
💉 Vaccination linked to lower long COVID risk, but protection isn't complete
Among 1,587 patients at post-COVID clinics in British Columbia, 58% were vaccinated but still developed persistent symptoms
Fully vaccinated non-hospitalized patients were less likely to report PTSD symptoms compared to unvaccinated patients
Patients infected with alpha and delta variants were more likely to report breathing problems than those with other variants
🏢 Long COVID creates major workplace challenges for both employees and managers
Interviews with 20 long COVID patients and 2 managers revealed that existing return-to-work support often fails to accommodate fluctuating symptoms
Problems included unrealistic phased return plans, managers ignoring occupational health advice, and unsuitable work adjustments
Financial pressure from reduced hours or sick leave was a main driver forcing people back to work before they were ready
🧠 Brain scans show lasting inflammation in some long COVID patients
MRI scans of 140 long COVID patients found signs of inflammation or nerve damage in 4% at 6 months after infection
7% showed cranial nerve enhancement (a sign of inflammation) that persisted up to 12 months, mainly affecting eye movement nerves
Most patients had normal brain scans, suggesting MRI is mainly useful for ruling out other conditions rather than diagnosing long COVID
📊 Machine learning identifies three distinct long COVID severity levels
Analysis of 1,661 patients across four medical centers found consistent patterns of mild, moderate, and severe long COVID symptoms
People with non-mild acute COVID had 2.6 times higher risk of developing moderate or severe long COVID compared to those with mild initial illness
The analysis identified 9-12 distinct symptom clusters per study site, with some linked to pre-existing conditions and female-predominant neurological symptoms
🏥 Long COVID patients cost healthcare systems 4 times more than typical patients
Spanish health system data showed long COVID patients (341 people) generated 4 times higher healthcare costs than control patients (49,078 people)
After diagnosis and coordinated care implementation, costs decreased primarily due to fewer primary care visits and hospitalizations
Long COVID patients were older with more cardiovascular risk factors like hypertension and type 2 diabetes
🏠 Dutch household study shows adults get persistent symptoms, children rarely do
Among 297 household members tested over 6 weeks, 201 (67.7%) got COVID-19, but only one child reported persistent symptoms at 6 months
COVID-positive adults were more likely to have lung symptoms (15.2% vs 3.4%) and fatigue (12.8% vs 3.4%) compared to COVID-negative adults
Adults with persistent symptoms had reduced quality of life and increased anxiety and depression
Implications
The research reveals long COVID as a complex, multi-system condition with genetic underpinnings, distinct symptom patterns, and significant workplace and healthcare impacts. While vaccines provide some protection and children are largely spared, millions of adults continue to struggle with persistent symptoms that require new approaches to diagnosis, treatment, and support.
Studies in this issue
Primary sources used for this newsletter.
- Using combined genetic and biological data to identify genes that may cause Long COVIDmain storyPLoS computational biology2025-12-01PMID 41325417
- Healthcare use by long COVID patients after starting an integrated care unitkey findingCost effectiveness and resource allocation : C/E2025-12-03PMID 41331825
- Ongoing Symptoms in People with and without COVID-19 Living in the Same Housekey findingJournal of medical virology2025-12-06PMID 41351342
- Link Between COVID-19 Vaccines, Virus Variants, and Long-Term Effectskey findingPloS one2025-12-02PMID 41329751
- Machine Learning Finds Different Groups, Severity Levels, and Patterns of Long COVID Symptomskey findingmedRxiv : the preprint server for health sciences2025-12-03PMID 41332817
- Long COVID and Work in the UK: Challenges, Support, and Viewskey findingArchives of public health = Archives belges de sante publique2025-12-05PMID 41345969
- Brain MRI Results in People with Long COVID: How They Change Over Timekey findingFrontiers in neurology2025-12-01PMID 41323230
Continue reading
All Long Covid issuesGet the next Long Covid issue
Seven papers, once a week. Free.